Similar articles

• Central action of 3-methoxy-4-hydroxymandelic acid in rats.

  Kleinrok Z, Jagiello-Wójtowicz E. Kleinrok Z, et al. Acta Physiol Pol. 1975 Sep-Oct;26(5):481-91. Acta Physiol Pol. 1975. PMID: 1241503 No abstract available.
• Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.

  Sieroslawska J, Hano J, Sypniewska M, Czarnecki R, Chojnacka-Wójcik E, Harasiewicz A. Sieroslawska J, et al. Pol J Pharmacol Pharm. 1973 Jan-Feb;25(1):1-16. Pol J Pharmacol Pharm. 1973. PMID: 4798097 No abstract available.
• Central effects of amines in adult fowls.

  Nisticò G, Marley E. Nisticò G, et al. Arch Int Pharmacodyn Ther. 1972 Apr;196:Suppl 196:136-. Arch Int Pharmacodyn Ther. 1972. PMID: 4340730 No abstract available.
• Central effects of endogenous and exogenous GABA.

  Czajka R. Czajka R. Acta Physiol Pol. 1978 May-Jun;29(3):193-205. Acta Physiol Pol. 1978. PMID: 707139
• [Pharmacological studies of hallucinogens. Report 3. I. Bibliographical considerations of psilocybin, with special reference to its actions on the central nervous system].

  Horibe M. Horibe M. Nihon Yakurigaku Zasshi. 1968 Mar;64(2):144-58. Nihon Yakurigaku Zasshi. 1968. PMID: 4881757 Review. Japanese. No abstract available.